Treatment of restless legs syndrome and periodic movements during sleep with L-dopa: A double-blind, controlled study

Neurology

Volumn 38, Issue 12, 1988, Pages 1845-1848

  Brodeur, C ^a   Montplaisir, J ^a   Godbout, R ^a   Marinier, R ^a  

^a UNIVERSITÉ DE MONTRÉAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

BENSERAZIDE; LEVODOPA;

ADULT; CLINICAL ARTICLE; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; ELECTROMYOGRAM; FEMALE; HUMAN; MALE; PRIORITY JOURNAL; RESTLESS LEGS SYNDROME; SLEEP MYOCLONUS;

BENSERAZIDE; CLINICAL TRIALS; DOUBLE-BLIND METHOD; FEMALE; HUMAN; LEVODOPA; MALE; MIDDLE AGE; MOVEMENT DISORDERS; PERIODICITY; QUESTIONNAIRES; REACTION TIME; RESTLESS LEGS SYNDROME; SLEEP; SUPPORT, NON-U.S. GOV'T;

EID: 0024243563     PISSN: 00283878     EISSN: 1526632X     Source Type: Journal    
DOI: 10.1212/wnl.38.12.1845     Document Type: Article

References (13)

1. Coleman RM. Periodic movements in sleep (nocturnal myoclonus) and restless legs syndrome. In: Guilleminault C, ed. Sleeping and waking disorders: indications and techniques. Palo Alto, CA: Addison-Wesley, 1982:265–295.
2. Montplaisir J, Godbout R, Boghen MD, deChamplain J, Young SN, Lapierre G. Familial restless legs with periodic movements in sleep: electrophysiologic, biochemical, and pharmacologic study. Neurology 1985;35:130–134.
3. Lugaresi E, Coccagna C, Berti-Ceroni G, Ambrosetto C. Restless legs syndrome and nocturnal myoclonus. In: Gastaut H, Lugaresi E, Berti-Ceroni G, eds. The abnormalities of sleep in man. Bologna, Italy: Aulo Gaggi, 1968:285–294.
4. Roth RH, Welters JR, Aghajanian GK. Effect of impulse flow on the release and synthesis of DA in the rat striatum. In: Usdin E, Snyder SH, eds. Frontiers in catecholamine research. New York: Pergamon Press, 1973:567–574.
5. Redgrave P, Taha EB, White L, Dean P. Increased food intake following the manipulation of intracerebral dopamine levels with gamma-hydroxybutyrate. Psychopharmacology (Berlin) 1982;76:273–277.
6. Akpinar S. Restless legs syndrome treatment with dopaminergic drugs. Clin Neuropharmacol 1987;10:69–79.
7. Montplaisir J, Godbout R, Poirier G, Bédard MA. Restless legs syndrome and periodic movements in sleep: physiopathology and treatment with L-dopa. Clin Neuropharmacol 1986;9:456–463.
8. Bédard MA, Montplaisir J, Godbout R. Effect of L-dopa on periodic movements in sleep in narcolepsy. Eur Neurol 1987;27:35–38.
9. Rechtschaffen A, Kales A. A manual of standardized terminology, techniques and scoring system for sleep stages of human subjects. Los Angeles: Brain Information Service/Brain Research Institute, 1968.
10. Mitler MM. The multiple sleep latency test as an evaluation for excessive somnolence. In: Guilleminault C, ed. Sleeping and waking disorders: indications and techniques. Menlo Park, CA: Addison-Wesley, 1982:145–153.
11. Guilleminault C, Mondini S, Montplaisir J, Mancuso D, Dement WC. Periodic leg movement, L-dopa, 5-hydroxytryptophan, and l -tryptophan. Sleep 1987;10:393–397.
12. Dzvonik ML, Kripke DF, Klauber M, Ancoli-Israel S. Body position changes and periodic movements in sleep. Sleep 1986;9:484–491.
13. Gillin JC, Rost RM, Wyatt RJ, Goddwin FK, Snyder F, Bunney WE Jr. REM inhibitory effect of L-dopa infusion during human sleep. Electroencephalogr Clin Neurophysiol 1973;35:181–186.